+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
Healthy Volunteers
ID07790211

Evaluating Tear Film Stability Detection Using iTrace, BOSA, OPD-Scan III, and IDRA with Miebo in Dry Eye

Led by Vance Thompson Vision · Updated on 2026-08-27

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the ability of four devicesthe iTrace, BOSA, OPD-Scan III, and IDRAto detect tear film stability using Miebo. This Phase 4 study focuses on dry eye and aims to assess how these devices measure tear film changes before and after administering Miebo. Participants will receive Miebo once in each eye during two visits. The study measures tear film stability by comparing baseline tear film index values to those recorded at 5 minutes, 30 minutes, and 1 hour after Miebo administration at both visits. Participants will attend two visits where assessments include tear film measurements using the specified devices. Researchers will monitor changes in tear film stability at multiple timepoints to evaluate device performance. The total study duration spans from August 2026 to September 2026, with safety and outcome data collected during these visits.

CONDITIONS

Brief Title

BL-RX01-TFSTAB-1402

Research Team

K

Kayla Karpuk, OD

G

Gabrielle Malmanger, CCRC, COA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here